NasdaqCM - Delayed Quote USD
Tempest Therapeutics, Inc. (TPST)
7.58
+0.44
+(6.16%)
At close: April 22 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-33,027
-33,027
-27,357
-31,072
-25,957
Investing Cash Flow
-435
-435
-170
-562
-97
Financing Cash Flow
24,500
24,500
35,602
11,403
59,063
End Cash Position
30,711
30,711
39,673
31,598
51,829
Income Tax Paid Supplemental Data
54
54
191
18
--
Interest Paid Supplemental Data
1,177
1,177
1,249
1,539
953
Capital Expenditure
-435
-435
-170
-562
-135
Issuance of Capital Stock
28,591
28,591
35,602
8,861
33,425
Issuance of Debt
--
--
--
--
15,000
Repayment of Debt
-4,398
-4,398
--
-4,739
--
Free Cash Flow
-33,462
-33,462
-27,527
-31,634
-26,092
12/31/2021 - 11/12/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DRUG Bright Minds Biosciences Inc.
33.50
+5.05%
CDIO Cardio Diagnostics Holdings, Inc.
0.4140
+11.89%
RNAZ TransCode Therapeutics, Inc.
0.3109
+3.63%
PTN Palatin Technologies, Inc.
0.2100
-9.09%
TSHA Taysha Gene Therapies, Inc.
1.7800
+22.76%
BCTX BriaCell Therapeutics Corp.
5.35
+27.68%
CCCC C4 Therapeutics, Inc.
1.5600
+11.43%
APVO Aptevo Therapeutics Inc.
0.6934
+9.08%
UNCY Unicycive Therapeutics, Inc.
0.6233
+2.16%
TNXP Tonix Pharmaceuticals Holding Corp.
14.96
0.00%